Literature DB >> 7530755

Expression of a candidate ataxia-telangiectasia group D gene in cultured fibroblast cell lines and human tissues.

Y Hosoi1, L N Kapp.   

Abstract

A candidate gene for ataxia-telangiectasia group D (ATDC) has been cloned (Kapp et al. 1992), sequenced and found to be a member of a recently reported gene family (Leonhardt et al. 1994). Transcriptional behaviour of ATDC has been examined in a number of cell lines and human tissues using a 3.0 kb cloned cDNA as a probe. Three normal and two ataxia-telangiectasia (A-T) group D, non-transformed fibroblast cell lines produced a 2.4 kb mRNA transcript. The size of mRNA transcripts seen and the level of expression differ in different human tissues. Many tissues have multiple transcripts of ATDC and the most prominent transcripts observed were 3.0, 2.4 and 1.6 kb. Two out of three SV-40 transformed normal and one SV-40-transformed A-T group D fibroblast cell lines demonstrated no transcription of ATDC by RNA blotting analysis. These results suggest that SV-40 transformation may affect the expression of ATDC. Reverse transcription-polymerase chain reaction analysis showed that ATDC was expressed at low levels in all of these cells. Additional Northern blot analysis demonstrated that X-irradiation with 10 Gy had no effect on ATDC expression at 1, 4 and 24 h after irradiation in either SV-40-transformed normal or in SV-40-transformed A-T group D fibroblast cell lines. Further understanding of ATDC will require cloning of additional transcripts and studies of ATDC protein behaviour.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7530755

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  5 in total

1.  Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.

Authors:  Christine A Iacobuzio-Donahue; Anirban Maitra; Grace L Shen-Ong; Tjarda van Heek; Raheela Ashfaq; Renee Meyer; Kimberly Walter; Karin Berg; Michael A Hollingsworth; John L Cameron; Charles J Yeo; Scott E Kern; Michael Goggins; Ralph H Hruban
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

2.  Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization.

Authors:  Lidong Wang; David G Heidt; Cheong J Lee; Huibin Yang; Craig D Logsdon; Lizhi Zhang; Eric R Fearon; Mats Ljungman; Diane M Simeone
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

3.  Tripartite motif-containing 29 expression in squamous cell carcinoma.

Authors:  Moon-Kyun Cho
Journal:  Ann Dermatol       Date:  2012-11-08       Impact factor: 1.444

4.  ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis.

Authors:  Lidong Wang; Huibin Yang; Andrea Zamperone; Daniel Diolaiti; Phillip L Palmbos; Ethan V Abel; Vinee Purohit; Igor Dolgalev; Andrew D Rhim; Mats Ljungman; Christina H Hadju; Christopher J Halbrook; Dafna Bar-Sagi; Marina Pasca di Magliano; Howard C Crawford; Diane M Simeone
Journal:  Genes Dev       Date:  2019-05-02       Impact factor: 11.361

5.  Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor.

Authors:  Tomoaki Naka; Yutaka Hatanaka; Yukiko Tabata; Akira Takasawa; Hideo Akiyama; Yasuhiro Hida; Hiromi Okada; Kanako C Hatanaka; Tomoko Mitsuhashi; Kei Kushitani; Vishwa Jeet Amatya; Yukio Takeshima; Kouki Inai; Kichizo Kaga; Yoshihiro Matsuno
Journal:  Diagnostics (Basel)       Date:  2022-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.